Research and Markets: Global Overview of the Biomarkers in Amyotrophic Lateral Sclerosis Market

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/l65wld/biomarkers_in) has announced the addition of the "Biomarkers in Amyotrophic Lateral Sclerosis - Overview " report to their offering.

Biomarkers have been a heavily studied topic of interest, and recently on the rise is the interest in neurodegenerative disorders, specifically Amyotrophic Lateral Sclerosis (ALS). This report covers extensive background information, highlights market growth and outlook, and features clinical trial and pipeline information.

Biomarkers in Amyotrophic Lateral Sclerosis is focused on the biomarker identification and development in patients with Amyotrophic Lateral Sclerosis (ALS). This report focuses on the ALS space featured in the parent report, highlighting several biomarker targets under investigation and the progress that has been made in the industry. With regards to employing the use of biomarkers for Amyotrophic Lateral Sclerosis, Biomarkers in Amyotrophic Lateral Sclerosis captures market growth of biomarkers, advantages, disadvantages, and validation techniques.

Experts interviewed in this report include:

Dr. Merit Ester Cudkowicz, Chief of Neurology at Massachusetts General Hospital

Dr. Andreas Jeromin, CSO and President of Atlantic Biomarkers

Also available in this report is extensive survey data exclusively conducted for this report. Illustrated by 30 figures captured by an in-depth analysis, this section features insight into targets under investigation, challenges, advantages, and desired features of future diagnostic applications.

Finally, the report concludes with clinical trial and pipeline data featuring targets and products from over 30 companies working in Amyotrophic Lateral Sclerosis.

Key Topics Covered:

Executive Summary

Chapter 1: The Focus Of This Report

Chapter 2: Biomarkers And Their Clinical Utility

Chapter 3: Biomarkers In Neurodegenerative Disorders

Chapter 4: Amyotrophic Lateral Sclerosis

Chapter 5: Biomarkers For Diagnostics

Chapter 6:Survey Results

Chapter 7: Clinical Trials And Pipeline Information For Amyotrophic Lateral Sclerosis*

For more information visit http://www.researchandmarkets.com/research/l65wld/biomarkers_in

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Healthcare and Medical Devices

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Healthcare and Medical Devices